Australia markets closed

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 12:06PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/11/2022
30/11/2021
30/11/2020
Total revenue
209.293
284.352
195.597
30
Cost of revenue
221.895
293.34
246.846
326.009
Gross profit
-12.602
-8.988
-51.249
-296.009
Operating expenses
Research development
58.801
125.378
1,074
1,880
Selling general and administrative
2,655
3,311
6,263
10,969
Total operating expenses
2,714
3,437
7,337
12,849
Operating income or loss
-2,726
-3,446
-7,389
-13,145
Interest expense
1,247
1,384
506.922
296.215
Total other income/expenses net
-
2,778
-345.063
-50.562
Income before tax
-485.457
-2,052
-8,241
-13,492
Income from continuing operations
-485.457
-2,052
-8,241
-13,492
Net income
-485.082
-2,052
-8,241
-13,492
Net income available to common shareholders
-1,909
-3,494
-8,741
-14,350
Basic EPS
-0.33
-0.08
-0.33
-0.65
Diluted EPS
-0.33
-0.08
-0.33
-0.65
Basic average shares
26,779
44,757
26,779
22,160
Diluted average shares
26,779
44,757
26,779
22,160